why choose us

First received: October 20, 2022

Clinical Trial: A Study of LY3540378 in Participants With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Heart Failure

Study Type: INTERVENTIONAL


Official Title: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of LY3540378 in Adults With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF

Brief Summary: The main purpose of this study is to assess the efficacy and safety of LY3540378 in adults with worsening heart failure with preserved ejection fraction

Read more